| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,946,005 |
|
|
|
Indirect Value
|
$5,005,151 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,951,156 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 14 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-15 |
4 |
AS |
$20.39 |
$509,750 |
D/D |
(25,000) |
1,063,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-05-01 |
4 |
AS |
$377.52 |
$514,182 |
D/D |
(1,362) |
42,452 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-08-10 |
4 |
OE |
$4.42 |
$525,332 |
D/D |
108,333 |
1,586,981 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-09-04 |
4 |
AS |
$145.90 |
$533,119 |
D/D |
(3,654) |
57,796 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-08-01 |
4 |
AS |
$146.30 |
$534,727 |
D/D |
(3,655) |
61,450 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-06-01 |
4 |
AS |
$398.87 |
$543,261 |
D/D |
(1,362) |
41,090 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2022-02-18 |
4 |
AS |
$30.65 |
$543,304 |
D/D |
(17,726) |
112,989 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-10-01 |
4 |
AS |
$242.85 |
$543,741 |
D/D |
(2,239) |
41,283 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-10-01 |
4 |
AS |
$149.16 |
$545,031 |
D/D |
(3,654) |
54,142 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-11-01 |
4 |
AS |
$245.57 |
$549,831 |
D/D |
(2,239) |
39,044 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-04-01 |
4 |
AS |
$423.20 |
$576,398 |
D/D |
(1,362) |
43,814 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President, CEO & Director |
• • – |
2003-10-09 |
4 |
S |
$7.80 |
$601,536 |
D/D |
(77,120) |
1,719,841 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-05-01 |
4 |
AS |
$285.43 |
$606,241 |
D/D |
(2,123) |
24,019 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-02-09 |
4 |
D |
$164.44 |
$612,210 |
D/D |
(3,723) |
46,958 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-04-01 |
4 |
AS |
$308.42 |
$654,776 |
D/D |
(2,123) |
26,142 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-11 |
4 |
AS |
$314.31 |
$771,945 |
D/D |
(2,456) |
52,961 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-01-02 |
4 |
AS |
$19.64 |
$783,715 |
D/D |
(39,904) |
1,403,127 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-08-01 |
4 |
AS |
$20.48 |
$823,738 |
D/D |
(40,000) |
1,128,031 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-02-10 |
4 |
D |
$118.14 |
$827,807 |
D/D |
(7,007) |
66,283 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-12-03 |
4 |
AS |
$21.16 |
$846,400 |
D/D |
(40,000) |
1,456,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-07-01 |
4 |
AS |
$21.58 |
$863,200 |
D/D |
(40,000) |
1,168,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-03-01 |
4 |
AS |
$22.66 |
$906,400 |
D/D |
(40,000) |
1,323,031 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-14 |
4 |
D |
$104.00 |
$914,264 |
D/D |
(8,791) |
54,374 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2011-07-15 |
4 |
D |
$104.00 |
$926,744 |
D/D |
(8,911) |
66,804 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-02-01 |
4 |
AS |
$23.53 |
$941,200 |
D/D |
(40,000) |
1,363,031 |
0 |
- |
|
376 Records found
|
|
Page 14 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
